help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 21, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1131
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/2/698    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldman, M. B.
Right arrow Articles by Pilla, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldman, M. B.
Right arrow Articles by Pilla, R. S.

Submitted on May 25, 2006
Accepted on November 9, 2006

Diminished Glucocorticoid Negative Feedback in Polydipsic Hyponatremic Schizophrenic Patients

Morris B. Goldman MD*, Gordon Wood MD, Megan B. Goldman BA, Michelle Gavin MD, Stacey Paul BS, Suhaila Zaheer MD, Ghazala Fayyaz MD, and Ramani S. Pilla

Department of Psychiatry, University of Chicago, Chicago, IL; Psychiatric Institute, University of Illinois at Chicago in affiliation with University of Chicago, Chicago, IL; Departments of Statistics and Biology, Case Western Reserve University, Cleveland, OH

* To whom correspondence should be addressed. E-mail: m-goldman{at}uchicago.edu.

Context: The mechanism and significance of diminished glucocorticoid negative feedback in schizophrenia is unknown, but is more commonly observed in schizophrenic patients with primary polydipsia. Polydipsic patients, especially those who are also hyponatremic, exhibit other neuroendocrine abnormalities that have been linked to hippocampal pathology.

Objective: To determine the effect of cortisol on plasma ACTH under conditions thought to be most sensitive to hippocampal influences.

Design: Repeated measures

Setting: Inpatient Clinical Research Center

Participants: Eight polydipsic hyponatremic, eight polydipsic normonatremic, as well as six schizophrenic patients without water imbalance. Eight healthy community volunteers matched for age and gender were also studied.

Intervention: Metyrapone (750 mg) was administered orally at 1430 and 1900 h. Beginning at 1930 h, hydrocortisone was infused over 150-min at 0.03 mg/kg/h. Blood samples and other measures were obtained at 20-min intervals from 1850 h to 2320 h.

Main Outcome Measures: Plasma ACTH and cortisol.

Results: ACTH levels did not decline significantly during the cortisol infusion in the polydipsic hyponatremic group. For any given level of cortisol, ACTH levels were higher in the hyponatremic group. While levels decline following cortisol in the other three groups, the decline was greatest in patients without water imbalance.

Conclusions: The marked impairment in glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients is consistent with hippocampal mineralocorticoid dysfunction.


Key words: metyrapone • cortisol • HPA • adrenocorticotropin • vasopressin • mental illness • water intoxication







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society